Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD4 Cell Counts”

160 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 160 results

Testing effectiveness (Phase 2)Study completedNCT00000771
What this trial is testing

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Who this might be right for
CryptosporidiosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 68
Early research (Phase 1)Study completedNCT00001041
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00002032
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia 750
Large-scale testing (Phase 3)UnknownNCT01289106
What this trial is testing

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects

Who this might be right for
HIV Infection
Chiang Mai University 132
Large-scale testing (Phase 3)Study completedNCT00001082
What this trial is testing

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 505
Not applicableStudy completedNCT00000908
What this trial is testing

Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 250
Testing effectiveness (Phase 2)Study completedNCT00189904
What this trial is testing

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 151
Not applicableStudy completedNCT01479634
What this trial is testing

Early HIV Therapy in Patients With High CD4 Cell Counts

Who this might be right for
HIV
University of California, San Francisco 279
Not applicableStudy completedNCT01225406
What this trial is testing

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Who this might be right for
This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy
The HIV Netherlands Australia Thailand Research Collaboration 56
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Post-approval studies (Phase 4)Study completedNCT01777997
What this trial is testing

FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 38
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00376935
What this trial is testing

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 99
Testing effectiveness (Phase 2)Study completedNCT00002233
What this trial is testing

A Combination of Four Drugs in Patients With Recent HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 30
Not applicableStudy completedNCT00002197
What this trial is testing

1592U89 in HIV-Infected Children

Who this might be right for
HIV Infections
Glaxo Wellcome 250
Not applicableStudy completedNCT00120510
What this trial is testing

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 816
Not applicableStudy completedNCT00002080
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia
Early research (Phase 1)Study completedNCT00000777
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancyHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)UnknownNCT00005002
What this trial is testing

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 688
Next Page